Moss Genomics (XCNQ:MOSS) ROCE % : -492.31% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Moss Genomics ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Moss Genomics's annualized ROCE % for the quarter that ended in Mar. 2024 was -492.31%.

Moss Genomics ROCE % Historical Data

The historical data trend for Moss Genomics's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moss Genomics ROCE % Chart

Moss Genomics Annual Data

Trend

Jun22

Jun23

ROCE %

-98.94

-197.56

Moss Genomics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial					-451.51	-339.39	-475.00	-580.00	-492.31

Moss Genomics ROCE % Calculation

Moss Genomics's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	-0.73	/	( ( (0.802 - 0.14)	+	(0.127 - 0.05) )	/ 2 )
	=	-0.73	/	( (0.662	+	0.077)	/ 2 )
	=	-0.73	/	0.3695
	=	-197.56 %

Moss Genomics's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-0.064	/	( ( (0.095 - 0.074)	+	(0.088 - 0.083) )	/ 2 )
	=	-0.064	/	( ( 0.021	+	0.005 )	/ 2 )
	=	-0.064	/	0.013
	=	-492.31 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Moss Genomics (XCNQ:MOSS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Moss Genomics ROCE % Related Terms

Thank you for viewing the detailed overview of Moss Genomics's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Moss Genomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Moss Genomics Inc (XCNQ:MOSS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1030 West Georgia Street, Suite 907, Vancouver, BC, CAN, V6E 2Y3

Website

https://www.mossgenomics.com

Moss Genomics Inc is an emerging consumer genomics company that offers personalized health, antiaging and wellness offerings guided by genomic, microbiome, and epigenome data. The Company intends to eliminate barriers in healthcare by offering easy-access, at-home, affordable testing paired with easy-to-understand actionable results.

Moss Genomics Headlines

No Headlines